Francini, E., Gray, K. P., Xie, W., Shaw, G. K., Valença, L., Bernard, B., . . . Sweeney, C. J. (2018). Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC). The Prostate, 78(12), 889-895. https://doi.org/10.1002/pros.23645
Citace podle Chicago (17th ed.)Francini, Edoardo, et al. "Time of Metastatic Disease Presentation and Volume of Disease Are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC)." The Prostate 78, no. 12 (2018): 889-895. https://doi.org/10.1002/pros.23645.
Citace podle MLA (9th ed.)Francini, Edoardo, et al. "Time of Metastatic Disease Presentation and Volume of Disease Are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC)." The Prostate, vol. 78, no. 12, 2018, pp. 889-895, https://doi.org/10.1002/pros.23645.